News from ESC 2024: Predicting 30-year CV outcomes in women

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
ESC 2024 - LDL-c, hsCRP, and Lp(a) predict 5-year to 10-year CVD risk, but do these biomarkers predict lifetime risk? The Women’s Health Study assessed the prognostic value of these 3 biomarkers for assessing long-term CVD risk using a single blood sample from 1993 in women.
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Paul M. Ridker, MD is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read the paper in N J Engl Med.
Release date: 2 September 2024

Recommended

Details

Presenters

Overview
ESC 2024 - LDL-c, hsCRP, and Lp(a) predict 5-year to 10-year CVD risk, but do these biomarkers predict lifetime risk? The Women’s Health Study assessed the prognostic value of these 3 biomarkers for assessing long-term CVD risk using a single blood sample from 1993 in women.
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Paul M. Ridker, MD is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read the paper in N J Engl Med.
Release date: 2 September 2024

Predicting 30-year CV outcomes in women